a.silva

TL2 · Zadar

Contributes reviews on supplier material. Based in Zadar.

Joined 22 May 2025 · last posted 10h

78 posts, newest first. Showing up to 150.

Second pass at: Reading a trial's population section before its results Replied, post #5 · Evidence › Trials · 27 Jul 2026 · 0 likes The first question about any trial is what it set out to estimate, not what it found. Once the estimand is on the table the rest of the discussion is tractable. If this…
Journal club: what we got wrong in an earlier session Replied, post #125 · Evidence › Journal club · 27 Jul 2026 · 19 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
Designing a personal experiment that could change your mind — one year on Replied, post #81 · Research Methods › N-of-1 designs · 26 Jul 2026 · 4 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
Private prescribing in the UK: what is actually involved Replied, post #72 · Regional › UK & Ireland · 22 Jul 2026 · 0 likes Confirming post #69 from a second method, which matters more than confirming it from a second person. The most useful thing anyone has posted about private prescribing…
Transit times by route, from a logged dataset Replied, post #19 · Sourcing › Logistics · 19 Jul 2026 · 24 likes Post #18 answers the question as asked. The question underneath it is different. Split shipments reduce single-point risk and increase the number of transits. Which…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #58 · Practice › Side effects · 18 Jul 2026 · 0 likes Nobody has said the unglamorous part of Muscle cramps yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Revisiting: The best-written scientific paper you have read Replied, post #93 · Lounge › Off topic · 15 Jul 2026 · 2 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
Tracking a shortage from primary sources rather than rumour Replied, post #103 · Access › Shortages · 15 Jul 2026 · 7 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect.
Shakes versus food: a pragmatic assessment Replied, post #23 · Nutrition & Training › Protein & intake · 11 Jul 2026 · 19 likes Coming back to post #21, because the follow-up matters more than the original answer. Two questions I would want answered before drawing anything from the shakes versus…
What a certificate commits its issuer to — one year on Replied, post #107 · Analytics › COA interpretation · 11 Jul 2026 · 2 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Pooling trials with different estimands Replied, post #87 · Evidence › Meta-analyses · 10 Jul 2026 · 0 likes Pooling trials with different estimands: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look,…
Follow-up: Reading an interaction checker output critically Replied, post #22 · Practice › Interactions · 28 Jun 2026 · 23 likes Reading an interaction checker output sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable…
Coming back to: A structured critique template this community uses Replied, post #39 · Evidence › Study critique · 21 Jun 2026 · 0 likes A definition problem is doing most of the work in this structured critique template discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
Endotoxin and why it is a separate question from purity — what changed since Replied, post #51 · Analytics › Impurities & related substances · 19 Jun 2026 · 28 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
Designing a personal experiment that could change your mind — one year on Replied, post #62 · Research Methods › N-of-1 designs · 18 Jun 2026 · 31 likes I think the Designing a personal experiment question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Micronutrient adequacy at low total intake Replied, post #54 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 22 likes Adding a null result on micronutrient adequacy. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Coming back to: Time to steady state after a dose increase Replied, post #73 · Pharmacology › Pharmacokinetics · 10 Jun 2026 · 0 likes Dose proportionality across the studied range means dose arithmetic behaves the way you would naively expect. It is worth checking whether it holds for a given compound…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #55 · Analytics › HPLC & UHPLC · 9 Jun 2026 · 8 likes Post #52 and I disagree about the size of the effect, not about the direction. Gradient slope is the single biggest driver of apparent purity differences. A shallower…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #70 · Practice › Administration · 6 Jun 2026 · 5 likes Noted, and I have changed what I was going to do on the strength of it.
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #128 · Practice › Storage & stability · 4 Jun 2026 · 27 likes Good question, well framed, and I would like to see it answered properly.
Revisiting: What pooling buys you and what it destroys Replied, post #34 · Evidence › Meta-analyses · 26 May 2026 · 4 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
Prescription portability between countries Replied, post #43 · Access › International · 25 May 2026 · 1 like I read post #41 twice before replying, because I had assumed the opposite. The failure mode on prescription portability between countries is boring rather than…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #39 · Practice › Storage & stability · 23 May 2026 · 19 likes On post #35 — agreed on the reasoning, with one qualification. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation…
CJC-1295 with and without DAC: what the modification does Replied, post #48 · Compounds › Secretagogues & GH axis · 3 May 2026 · 19 likes That matches what I have seen, for whatever a single anecdote is worth.
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #42 · Evidence › Trials · 12 Apr 2026 · 26 likes Something worth flagging about Subgroup analyses: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #19 · Clinical › Bloodwork · 7 Apr 2026 · 1 like Answering the question post #15 raises rather than the one it answers. Adding a null result on Liver enzymes drifting. I looked, carefully, and found nothing, and null…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #3 · Pharmacology › Pharmacokinetics · 1 Apr 2026 · 4 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
Managing an unplanned gap in supply Replied, post #71 · Access › Shortages · 23 Mar 2026 · 26 likes Post #69 is right about the mechanism and I think understates the practical bit. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
Personal import allowances, compared — a second dataset Replied, post #87 · Access › International · 18 Mar 2026 · 13 likes Worth separating Personal import allowances as a question about the compound from Personal import allowances as a question about the documentation. They get answered by…
Measurement error in home scales, with a worked standard deviation Replied, post #21 · Research Methods › Statistics · 10 Mar 2026 · 10 likes The version of measurement error in home scales that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
A widely repeated interaction claim that turns out to be unsupported Replied, post #30 · Practice › Interactions · 22 Feb 2026 · 0 likes Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in…
Measurement error in a self-reported exposure Replied, post #13 · Evidence › Study critique · 22 Feb 2026 · 17 likes On post #9 — agreed on the reasoning, with one qualification. Criticism is more useful when it is narrower. "The trial answers a different question from the one being…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #20 · Compounds › Tirzepatide · 19 Feb 2026 · 14 likes Where I part company with post #17, and it is a narrow parting. Careful with the language on 2.5 mg starting dose. "Not detected" and "not present" are different…
Research-use-only labelling: what it means and what it does not Replied, post #100 · Sourcing › Regulatory · 9 Feb 2026 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #14 · Analytics › Mass spectrometry · 21 Jan 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #28 · Regional › UK & Ireland · 1 Jan 2026 · 0 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
Availability by country, dated, with primary sources — one year on Replied, post #8 · Access › International · 19 Dec 2025 · 6 likes Picking up post #7: that is the part I would want checked first. Date your answer and name your region. A position that is true in one jurisdiction and stated without…
The decimal-point error, and the habit that catches it Replied, post #81 · Practice › Reconstitution · 17 Dec 2025 · 4 likes Where I part company with post #80, and it is a narrow parting. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
Micro-titration: a disputed topic, argued properly Replied, post #4 · Practice › Dosing & titration · 17 Nov 2025 · 11 likes Micro-titration is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
High-resolution MS on aggregates and what it can see Replied, post #118 · Analytics › Mass spectrometry · 12 Nov 2025 · 17 likes I read post #114 twice before replying, because I had assumed the opposite. Resolution and mass accuracy are different specifications. An instrument can resolve two…
How to ask about something you suspect is a bad idea Replied, post #20 · Start Here › How to Ask · 29 Oct 2025 · 1 like Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
New subcategory: rationale and scope Replied, post #125 · Meta › Announcements · 26 Oct 2025 · 21 likes If you are new and reading this thread for the answer to new subcategory: the answer is conditional, the conditions are in the third reply, and the rest of the thread…
Tracking that stops updating and then resumes Replied, post #33 · Sourcing › Logistics · 6 Oct 2025 · 12 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #81 · Evidence › Preprints · 2 Oct 2025 · 6 likes Citing a preprint has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Second pass at: Programming during a large energy deficit Replied, post #15 · Nutrition & Training › Resistance training · 22 Sep 2025 · 0 likes Performance usually declines somewhat during a substantial deficit, and expecting it to improve is the most common source of disappointment reported here.
Follow-up: Why appetite effects are mostly central Replied, post #39 · Pharmacology › Receptor biology · 12 Sep 2025 · 4 likes I had written a reply contradicting post #37 and deleted it. Here is what survived. I would call the community position on appetite effects likely rather than…
Substitution between formats during a shortage Replied, post #43 · Access › Shortages · 22 Aug 2025 · 10 likes Confirming post #42 from a second method, which matters more than confirming it from a second person. Allocation and rationing: during severe shortages, suppliers might…
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #27 · Start Here › Welcome · 17 Aug 2025 · 17 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
What a documentation review can and cannot tell you Replied, post #57 · Sourcing › Independent verification · 2 Aug 2025 · 0 likes I had written a reply contradicting post #53 and deleted it. Here is what survived. It does not extend to lots nobody has seen, it is not a recommendation, and it says…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #2 · Practice › Side effects · 22 Jul 2025 · 9 likes Hair shedding some months in is described frequently here and is more consistent with rapid weight loss than with any direct drug effect. That distinction matters…
Coming back to: When "no data" is the complete and final answer Replied, post #54 · Compounds › Other compounds · 22 Jul 2025 · 0 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #12 · Compounds › Retatrutide · 15 Jul 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #8 · Compounds › Semaglutide · 27 Jun 2025 · 0 likes Offering a way to settle semaglutide solutions rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
Trial registration and comparing the protocol with the paper Replied, post #16 · Evidence › Trials · 22 Jun 2025 · 17 likes The honest answer on trial registration is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.…
[2026 update] An appeal that failed, and what I would do differently Replied, post #123 · Access › Insurance & coverage · 15 Jun 2025 · 23 likes Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose.
Anxiety in the first weeks: drug, situation, or both Replied, post #102 · Wellbeing › Mental health · 13 Jun 2025 · 6 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters. If…
Price changes over 2025 and 2026, tabulated and dated Replied, post #3 · Access › Pricing · 30 May 2025 · 28 likes Where a price includes consultation, device and follow-up, saying so makes a comparison possible. Most quoted figures do not.
Pre-registering a personal experiment, seriously Replied, post #34 · Research Methods › N-of-1 designs · 28 May 2025 · 2 likes Regression to the mean explains a great many personal experiments. People start when things are at their worst, and things at their worst tend to improve.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #113 · Practice › Reconstitution · 22 May 2025 · 0 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
Asking about a compound your prescriber has not heard of Replied, post #43 · Clinical › Prescriber conversations · 19 May 2025 · 0 likes I read post #39 twice before replying, because I had assumed the opposite. If you have been doing something the prescriber does not know about, saying so is more useful…
Coming back to: Why the cheapest option is often not the cheapest Replied, post #19 · Access › Pricing · 5 May 2025 · 0 likes The thing about cheapest option that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Washout: how long is long enough, and for what purpose Replied, post #23 · Pharmacology › Pharmacokinetics · 3 May 2025 · 33 likes Coming back to post #19, because the follow-up matters more than the original answer. Where I have landed on washout, having got it wrong once in public: the direction…
A claim built entirely on a subgroup analysis Replied, post #4 · Evidence › Study critique · 24 Apr 2025 · 28 likes Adding a data point of agreement rather than a data point.
Requesting a page: what makes a good request Replied, post #68 · Documentation › Wiki requests · 23 Apr 2025 · 16 likes Adding the measurement that post #65 says would settle it. Correction requests: if you spot an error in a maintained page, note it here with the specific correction.…
Telehealth prescribing models in the US Replied, post #64 · Regional › North America · 28 Feb 2025 · 2 likes I would rather this thread reach "we do not know" about telehealth prescribing models than reach a confident answer that nobody can support when asked.
Counter-ion form: the field almost nobody reports — one year on Replied, post #32 · Analytics › COA interpretation · 27 Feb 2025 · 0 likes Post #29 is right about the mechanism and I think understates the practical bit. Check the lot on the vial against the lot on the document before anything else. It is…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #45 · Access › International · 15 Feb 2025 · 3 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #101 · Evidence › Meta-analyses · 12 Feb 2025 · 8 likes Random versus fixed effects looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Fixed versus detachable needles: the trade-offs Replied, post #104 · Devices › Syringes & needles · 10 Jan 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #4 · Clinical › Comorbidities · 7 Jan 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Taking Heart failure with preserved ejection seriously for a moment rather than…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #29 · Sourcing › Red flags · 21 Dec 2024 · 3 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. I would want the raw…
Promotion criteria, and the one that stops most nominations Replied, post #133 · Documentation › Doc review · 6 Dec 2024 · 7 likes I read post #129 twice before replying, because I had assumed the opposite. Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #23 · Compounds › Secretagogues & GH axis · 19 Nov 2024 · 11 likes One more thing on pulsatile secretion that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #8 · Sourcing › Red flags · 22 Oct 2024 · 29 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports.
Irish differences from the UK position Replied, post #35 · Regional › UK & Ireland · 13 Oct 2024 · 15 likes Where I part company with post #31, and it is a narrow parting. Where the compound is supplied with a device, the device and the compound have separate availability…
About the International category Replied, post #12 · Access › International · 10 Oct 2024 · 0 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page.
Air bubbles in a subcutaneous injection: the honest risk assessment Replied, post #5 · Practice › Administration · 4 Oct 2024 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
Circumference measurements as a poor man's composition estimate Replied, post #108 · Outcomes › Body composition · 29 Aug 2024 · 1 like Circumference measurements: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…